These findings suggest that IOE treatment ameliorates insulin resistance by activating the IRS/PI3K/Akt signaling pathway in muscle and WAT, and in tandem with its effect to increase GLUT4 expression, this results in an amelioration of glucose intolerance. The gene discussed is SLC2A4; the disease is Insulin resistance.